Perimenopause is highly impairing for women with ADHD, who experience more severe symptoms and at an earlier age than neurotypical women.
By Nathaly Pesantez | Updated on June 9, 2026
Perimenopause is the most impairing phase of life for women with ADHD. From worsening ADHD symptoms to mood changes and sleep issues to brain fog, fluctuating and decreasing estrogen levels wreak havoc on the lives of women with ADHD, whose brains are far more sensitive to hormonal changes. (In an ADDitude survey, 94% of women said their ADHD symptoms grew more severe during perimenopause and menopause.) Despite this, many neurodivergent women going through this transition still aren’t getting adequate care.
“Perimenopause is when you need the most help, the most support,” said Patricia O. Quinn, M.D., during her May 6 ADDitude webinar, “Perimenopause in Women with ADHD.” “You need to take care of yourself during this time.”
Here’s what all women with ADHD and their health care providers should know about the perimenopausal transition.
Perimenopause Occurs Earlier in Women with ADHD
Perimenopause begins up to 10 years earlier for women with ADHD, who report in one study that their more severe perimenopause symptoms occurred between the ages of 35 and 39, compared to ages 45 and 49 for neurotypical women.
What’s more, women with ADHD report more severe perimenopause symptoms across all categories — somatic (e.g., hot flashes), psychological (e.g., depressive mood), and urogenital (e.g., vaginal dryness) — compared to women without ADHD.
“This is something that needs to be addressed in women with ADHD in addition to their ADHD symptoms,” Quinn said.
Estrogen and Medication Changes May Be Warranted
Research on the most effective treatments for ADHD during perimenopause is limited, but available data and observational evidence suggest that many women benefit from estrogen supplementation and increased stimulant dosages during this phase.
“Estrogen… makes your stimulant more effective,” Quinn said, emphasizing that all treatment decisions must be made in consultation with a doctor who considers the patient’s family medical history and individual risk factors.
Read more on ADDitude.
By Nathaly Pesantez | Updated on June 9, 2026
Perimenopause is the most impairing phase of life for women with ADHD. From worsening ADHD symptoms to mood changes and sleep issues to brain fog, fluctuating and decreasing estrogen levels wreak havoc on the lives of women with ADHD, whose brains are far more sensitive to hormonal changes. (In an ADDitude survey, 94% of women said their ADHD symptoms grew more severe during perimenopause and menopause.) Despite this, many neurodivergent women going through this transition still aren’t getting adequate care.
“Perimenopause is when you need the most help, the most support,” said Patricia O. Quinn, M.D., during her May 6 ADDitude webinar, “Perimenopause in Women with ADHD.” “You need to take care of yourself during this time.”
Here’s what all women with ADHD and their health care providers should know about the perimenopausal transition.
Perimenopause Occurs Earlier in Women with ADHD
Perimenopause begins up to 10 years earlier for women with ADHD, who report in one study that their more severe perimenopause symptoms occurred between the ages of 35 and 39, compared to ages 45 and 49 for neurotypical women.
What’s more, women with ADHD report more severe perimenopause symptoms across all categories — somatic (e.g., hot flashes), psychological (e.g., depressive mood), and urogenital (e.g., vaginal dryness) — compared to women without ADHD.
“This is something that needs to be addressed in women with ADHD in addition to their ADHD symptoms,” Quinn said.
Estrogen and Medication Changes May Be Warranted
Research on the most effective treatments for ADHD during perimenopause is limited, but available data and observational evidence suggest that many women benefit from estrogen supplementation and increased stimulant dosages during this phase.
“Estrogen… makes your stimulant more effective,” Quinn said, emphasizing that all treatment decisions must be made in consultation with a doctor who considers the patient’s family medical history and individual risk factors.
Read more on ADDitude.
